Insulin-producing β cells created from human pluripotent stem cells have potential as a
therapy for insulin-dependent diabetes, but human pluripotent stem cell-derived islets (SC …

Islet transplantation holds significant promise as a curative approach for type 1 diabetes
(T1D). However, the transition of islet transplantation from the experimental phase to …

Diabetes mellitus is a chronic metabolic disease, characterized by high blood sugar levels; it
affects more than 500 million individuals worldwide. Type 1 diabetes mellitus (T1DM) is …

Type 1 diabetes is an autoimmune disease associated with the destruction of insulin-
producing β cells. Immunotherapies are being developed to mitigate autoimmune diabetes …

Diabetes presents a pressing healthcare crisis, necessitating innovative solutions. Organoid
technologies have rapidly advanced, leading to the emergence of bioengineering islet …

Background Research on diabetes remission has garnered prominence in recent years.
However, to date, no pertinent bibliometric study has been published. This study sought to …

Stem cell‐derived pancreatic progenitors (SC‐PPs), as an unlimited source of SC‐derived β
(SC‐β) cells, offers a robust tool for diabetes treatment in stem cell‐based transplantation …

Background. Type 1 diabetes is an autoimmune disease characterized by T-cell–mediated
destruction of pancreatic beta-cells. Islet transplantation is an effective therapy, but its …

Aims/hypothesis Stem cell-derived islets (SC-islets) are being used as cell replacement
therapy for insulin-dependent diabetes. Non-invasive long-term monitoring methods for SC …

Human allogeneic pancreatic islet transplantation is a life-changing treatment for patients
with severe Type 1 Diabetes (T1D) who suffer from hypoglycemia unawareness and high …